MDI Health

MDI Health Overview

MDI Health has developed an AI-driven pharmacology platform capable of performing multidimensional context-based analyses of thousands of pharmacological and patient-specific parameters in order to autonomously optimize personal medication regimens across the entire population. The company’s powerful artificial intelligence is used by payers and value-based providers to identify high-risk patients for adverse drug events, to make changes in order to reduce those risks in real time, and to execute the given recommendations, thereby reducing total care costs while improving quality.

Cumulative Funding Raised Over Time ($)

Latest News

Feb 2, 2023 · www.calcalistech.com

growth-positive

MDI Health raises $20 million for customized AI medication platform | CTech

Israeli startup MDI Health has raised $20 million in funding led by Intel Capital. The company develops a platform that helps manage medication and customize it for each patient. MDI Healths technology automates comprehensive medication reviews (CMRs) for clinicians, allowing them to complete them in minutes instead of hours. The funding will be used to meet customer demand, expand research and development teams, and increase the companys valuation. MDI Healths mission is to prevent drug-related medical problems, which is the fourth leading cause of death in the United States.

InvestmentExpand

Mar 30, 2022 · www.bloomberg.com

Neutral

https://www.bloomberg.com/press-releases/2022-03-01/healthcare-veteran-joins-mdi-health-as-coo-advancing-its-automated-pharmacology-intelligence-platform-to-optimize-medication

The article is a brief description of Bloombergs Daybreak Europe program. It is anchored live from London and provides breaking news from Europe and around the world. The program also allows investors to monitor their investments 24 hours a day, around the clock from around the globe.

Jan 4, 2022 · www.businesswire.com

Long-Time CEO of Blue Cross Blue Shield AZ, Richard Boals, Joins MDI Health

Jun 29, 2021 · www.calcalistech.com

growth-positive

MDI Health announces $6 million seed round, launches personalized AI medication platform

Israeli startup MDI Health has launched its end-to-end AI platform for personalized medication. Recent clinical trials at Hadassah University Hospital in Israel showed that the AI platform presented up to 40% more life-saving patient insights than clinical pharmacists had identified. MDI Health has completed a $6 million seed round led by Hanaco Ventures, bringing its total funding to $7 million. The company aims to solve medication-related problems, which is the fourth-largest cause of world deaths. MDI Health has also announced the launch of new pilots in the U.S. with a top health insurer and health systems.

InvestmentPartners

Dec 13, 2019 · www.jpost.com

growth-positive

https://www.jpost.com/Opinion/Hillels-Tech-Corner-MDI-Health-brings-precision-to-medical-prescriptions-610782

MDI Health is a company that uses AI algorithms and machine learning models to improve medication treatment and prevent medication-related problems. They aim to blend expert human intelligence with machine intelligence for better medication management. The company has raised a pre-seed funding round led by Jumpspeed VC and Freshfund. The impact of MDI Health is positive for both patients and clinicians, as it provides safer and more personalized medication treatment. The article discusses the challenges in medical prescriptions and the need for a paradigm shift in medication management.

Customers

Funding

Team Members

4

Employees: 51-200

Web & Social Links

Locations

Tel Aviv-Yafo, Israel

Los Angeles, CA, USA

Photos & Videos

No files yet

MDI Health Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info